Clinicians must make sure patients are engaged in their care, stressed Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy.
Clinicians must talk to their patients, because it may help to uncover possible gaps in their medication access, which can be helpful to addressing overall medication persistence and care engagement, stressed Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University Chicago College of Pharmacy, who practices at Northwestern Medicine's Infectious Disease Center in Chicago.
Transcript
How can managed care professionals collaborate with clinicians to ensure persons living with or at risk of HIV remain engaged in their care?
We know that there's literature showing that attending clinic appointments is associated with medication persistence. So medication persistence is filling every month, being adherent over a span of time. And this type of question could be added into just the general questions, such as shipping information, if they're coming from a mail order pharmacy, or just even at the point of dispense, [such as asking], “Oh, when's your next follow-up appointment?” And if somebody hasn't been there in over a year or it's coming up on a year to get that appointment scheduled, specialty pharmacies are really able to get this information from the electronic medical record. So for example, if I'm looking and trying to refill a prescription, I might, you know, say, “Oh, gosh, this patient hasn't been here in however many months,” or the last note said, “Follow up in 3 months,” and it's been more than that now.
And we want to make sure they're seen at least once a year, that they're considered engaged in care, as well as if managed care can give feedback on refill history to the prescriber so that when that patient comes to an appointment, the prescriber can look and say, “Okay, you fill basically exactly on the 28th of every month. This is really great,” or, “Hey, back in July, I see there was a 2-week time where you didn't have a medication supply, based on this refill history,” and the patient might say, “Oh, yeah, I was out of town, I forgot,” or they might say, “Well, you know, I had pills built up over time, so I had all these extra. I was just letting those run out before I went and got my next refill.” So I think having that conversation can really lead to ideas about gaps in medication access, and that might be something that's helpful.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More